Skip to content

*IBDome; Identification of rare variants in candidate genes and regulatory elements in familiar and sporadic early-onset IBD (inflammatory bowel disease) patients*

*IBDome; Identification of rare variants in candidate genes and regulatory elements in familiar and sporadic early-onset IBD (inflammatory bowel disease) patients* - IBDome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41478
Enrollment
Unknown
Registered
2013-11-22
Start date
2015-04-23
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease ulcerative colitis or Crohn

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosis of IBD according to the IBD guidelines including endoscopic investigation with histologic abnormalities suspicious for IBD. (2) Age at diagnosis between 0- 17 years (3) Family member of pediatric IBD patient

Exclusion criteria

Exclusion criteria: No informed consent obtained for present study. We will refrain from taking the extra blood for our research if the venipuncture is difficult to perform and/or the child is distressed.

Design outcomes

Primary

MeasureTime frame
Identification of rare variants in IBD candidate genes by analyzing the differences in genetic profile between patients and family members and between patients and controls. Major goal is to extend our understanding of genetic components in sporadic cases of early onset IBD with an emphasis on rare variants and to identify individual causative mutations in familial cases. We will correlate clinical information (age of onset, clinical data, associated diseases) with observed variants of candidate genes. In familiar cases, only affected family members will be sequenced by next generation sequencing. Unaffected family members will be sequenced by traditional Sanger sequencing for variants identified in the affected family members.

Secondary

MeasureTime frame
When we find novel diagnostic genes, the Diagnostic Section of Medical Genetics might include sequencing of the new gene(s) into their standard pipeline. This practical implementation of our study will be done according to their diagnostic standards and internal protocols.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)